Aspirin/Hydroxycarbamide/OctreotideLack of efficacy and treatment non-compliance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75723-8

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：57 / 57

相关论文

共 50 条

[41] OctreotideLack of efficacy: case report
Reactions Weekly, 2022, 1903 (1) : 298 - 298
[42] OctreotideLack of efficacy: case report
Reactions Weekly, 2023, 1955 (1) : 300 - 300
[43] OctreotideLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 404 - 404
[44] OctreotideLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 460 - 460
[45] OctreotideLack of efficacy: case report
Reactions Weekly, 2020, 1818 (1) : 215 - 215
[46] OctreotideLack of efficacy: case report
Reactions Weekly, 2022, 1894 (1) : 259 - 259
[47] Colchicine/methylprednisoloneNo therapeutic response and treatment non-compliance : case report
Reactions Weekly, 2024, 2020 (1) : 154 - 154
[48] Psychodynamic therapy for non-compliance: a case report
Saha, Shanthi
McCarthy, Claire
Dhillon, Rohan
AUSTRALASIAN PSYCHIATRY, 2019, 27 (03) : 288 - 290
[49] Calcium/vitamin DHypocalcaemia due to treatment non-compliance: case report
Reactions Weekly, 2017, 1646 (1) : 75 - 75
[50] Multiple drugsPathogen resistance and intentional treatment non-compliance: case report
Reactions Weekly, 2025, 2046 (1) : 292 - 292

← 1 2 3 4 5 →